Literature DB >> 12753917

In vivo stabilization of nuclear retinoid X receptor alpha in the presence of peroxisome proliferator-activated receptor alpha.

Naoki Tanaka1, Kazuhiko Hora, Hideki Makishima, Yuji Kamijo, Kendo Kiyosawa, Frank J Gonzalez, Toshifumi Aoyama.   

Abstract

Retinoid X receptor alpha (RXRalpha) can reveal diverse functions through forming a heterodimer with peroxisome proliferator-activated receptor alpha (PPARalpha). However, the mechanism of regulation of the cellular RXRalpha level is unclear. Thus, quantitative change of RXRalpha was investigated in mouse liver. Nuclear RXRalpha level was constitutively lower in PPARalpha-null mice than in wild-type mice. The level was also increased by clofibrate treatment in wild-type mice without a concomitant increase of RXRalpha mRNA, but not in PPARalpha-null mice. Pulse chase experiments demonstrated that the presence of PPARalpha and its activation by ligands significantly affected the stability of nuclear RXRalpha. These findings suggest a novel regulatory mechanism of nuclear RXRalpha in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12753917     DOI: 10.1016/s0014-5793(03)00423-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Polyenephosphatidylcholine prevents alcoholic liver disease in PPARalpha-null mice through attenuation of increases in oxidative stress.

Authors:  Wataru Okiyama; Naoki Tanaka; Tamie Nakajima; Eiji Tanaka; Kendo Kiyosawa; Frank J Gonzalez; Toshifumi Aoyama
Journal:  J Hepatol       Date:  2009-04-02       Impact factor: 25.083

2.  Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism.

Authors:  Takero Nakajima; Naoki Tanaka; Hiroki Kanbe; Atsushi Hara; Yuji Kamijo; Xiaowei Zhang; Frank J Gonzalez; Toshifumi Aoyama
Journal:  Mol Pharmacol       Date:  2009-01-05       Impact factor: 4.436

3.  PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.

Authors:  Naoki Tanaka; Kyoji Moriya; Kendo Kiyosawa; Kazuhiko Koike; Frank J Gonzalez; Toshifumi Aoyama
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

4.  Peroxisome proliferator-activated receptor and retinoic x receptor in alcoholic liver disease.

Authors:  Tommaso Mello; Simone Polvani; Andrea Galli
Journal:  PPAR Res       Date:  2009-09-14       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.